BOSCHI, Donatella
Dettaglio
BOSCHI, Donatella
SCIENZA E TECNOLOGIA DEL FARMACO
Pubblicazioni
Risultati 1 - 20 di 137 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 1H-pyrazole-4-carboxylic acids active against Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH): discovery of a new scaffold for development of antimalarial agents | 2014 | Agnese Chiara Pippione; Ulf J. Nilsson; Ingela Fritzson; Anders P. Sundin; Salam Al-Karadaghi; Donatella Boschi; and Marco Lucio Lolli |
2 | 4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site | 2018 | Giraudo, Alessandro; Krall, Jacob; Nielsen, Birgitte; Sørensen, Troels E.; Kongstad, Kenneth T.; Rolando, Barbara; Boschi, Donatella; Frølund, Bente; Lolli, Marco L. |
3 | 4-Hydroxy-1H-1,2,3-Triazol-5-yl moiety as bioisoster of carboxylic group. Synthesis and pharmacological ionotropic glutamate receptors characterization of Glu analogues | 2014 | S. Sainas; A. Federico;C. Bertolotti; B. Nielsen; D. Boschi; B. Frølund and M. L. Lolli |
4 | 4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade | 2017 | Pippione, Agnese C.; Federico, Antonella; Ducime, Alex; Sainas, Stefano; Boschi, Donatella; Barge, Alessandro; Lupino, Elisa; Piccinini, Marco; Kubbutat, Michael; Contreras, Jean-Marie; Morice, Christophe; Al-Karadaghi, Salam; Lolli, Marco L. |
5 | 6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity | 2013 | Boschi D.; Tosco P.; Chandra N.; Chaurasia S.; Fruttero R.*; Griffin R.; Wang L.-Z.; Gasco A. |
6 | A New Synthetic Approach to Substituted β-Carboline Systems | 1999 | GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO |
7 | Activity of calvatic acid and its analogs against Helicobacter pylori | 2001 | BOSCHI D.; C. CENA; FRUTTERO R.; BRENCIAGLIA M. I.; SCALTRITO M. M.; DUBINI F.; GASCO A. |
8 | AKR1C3 is a biomarker and druggable target for oropharyngeal tumors | 2021 | Peraldo-Neia C.; Ostano P.; Mello-Grand M.; Guana F.; Gregnanin I.; Boschi D.; Oliaro-Bosso S.; Pippione A.C.; Carenzo A.; De Cecco L.; Cavalieri S.; Micali A.; Perrone F.; Averono G.; Bagnasacco P.; Dosdegani R.; Masini L.; Krengli M.; Aluffi-Valletti P.; Valente G.; Chiorino G. |
9 | ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN | 1994 | D. BOSCHI; A. DI STILO; R. FRUTTERO; C. MEDANA; G. SORBA; A. GASCO |
10 | Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention | 2017 | Pippione, Agnese C.; Boschi, Donatella; Pors, Klaus; Oliaro-Bosso, Simonetta; Lolli, Marco L. |
11 | Antileishmanial activity of some 4-phenyl-3-amino-1H-pyrazols designed as CRK3 kinase inhibitors | 2016 | Agnese Chiara Pippione, Piermichele Kobauri, Stefano Sainas, Alberto Gimenez, Antonella Federico, Rodolpho Campos Braga, Carolina Horta Andrade, Donatella Boschi, Efrain Salamanca, Juan Carlos Ticona, Marco Lucio Lolli |
12 | Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor | 2021 | Sainas Sainas, Circosta Paola, Pippione Agnese Chiara, Giorgis Marta, Marraudino Marilena, Houshmand Mohammad, Bonaldo Brigitta, Gaidano Valentina, Cignetti Alessandro, Saglio Giuseppe, Al-Karadaghi Salam, Boschi Donatella, Lolli Marco Lolli |
13 | APPLICATION OF THE ARACHNO™ TECHNOLOGY FOR THE PARALLEL SYNTHESIS OF A LIBRARY OF ASPIRIN ANALOGUES | 2015 | Moreo, Angela; Barge, Alessandro; Boschi, Donatella; Costale, Annalisa; Dosio, Franco; Federico, Antonella; Stevanato, Livio; L. Lolli., Marco |
14 | Application of the arachno™ technology inside Educational fields: the introduction of parallel synthesis concepts inside an undergraduated lab | 2016 | L. Lolli, Marco; *a, ; Angela Moreo, B; Alessandro Barge, A; Donatella Boschi, A; Annalisa Costale, A; Livio Stevanatoa and Franco Dosioa |
15 | Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists | 2000 | SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO |
16 | Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists | 2000 | S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco |
17 | Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | 2019 | Lolli, Marco L; Carnovale, Irene M; Pippione, Agnese C; Wahlgren, Weixiao Y; Bonanni, Davide; Marini, Elisabetta; Zonari, Daniele; Gallicchio, Margherita; Boscaro, Valentina; Goyal, Parveen; Friemann, Rosmarie; Rolando, Barbara; Bagnati, Renzo; Adinolfi, Salvatore; Oliaro-Bosso, Simonetta; Boschi, Donatella |
18 | Characterisation of Furoxancarbonitriles as a New Class of Vasodilators | 1998 | A.M. GASCO; D. BOSCHI; A. DI STILO; C. MEDANA; A. GASCO; P.A. MARTORANA; K. SCHONAFINGER |
19 | Design and synthesis of a library of pyrazolo[1,5-a]pyridine fluorophores for developing new fluorescent probes | 2021 | Elena Martino, Stefano Sainas, Francesco Bavo, Claudio Garino, Donatella Boschi, Bente Frølund, Marco Lucio Lolli |
20 | Design of new human Dihydroorotate Dehydrogenase inhibitors: amide bioisosterism in MEDS433 optimization | 2021 | Martino, Elena; Villella, Noemi;Vigato, Chiara; Cerrina, Matteo; Bersani, Matteo; Giorgis Marta, Sainas, Stefano.; Boschi, Donatella; Lolli, Marco Lucio |